| Title |
Author |
Type |
Date |
Words |
| Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases. |
Bruni, Cosimo; Cigolini, Cosimo; Tesei, Giulia; Cometi, Laura; Bartoli, Francesca; Fiori, Ginevra; N |
Report |
Oct 1, 2021 |
4949 |
| Biologic treatment mitigates PsA risk in psoriasis patients, study finds. |
Splete, Heidi |
|
Oct 1, 2021 |
890 |
| In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls. |
Tenstad, Helene Broch; Vinholt, Pernille Just; Nielsen, Christian; Lindegaard, Hanne; Just, Soren An |
Report |
Oct 1, 2021 |
4235 |
| SPECTRUM OF RHEUMATOID ARTHRITIS PATIENTS PRESENTING TO A TERTIARY CARE HOSPITAL IN PAKISTAN. |
Muhammad Khan, Muhammad Salman Mushtaq, Babur Salim, Sumera Mushtaq, Haris Gul and Saba Samreen |
|
Aug 31, 2021 |
2692 |
| Xeljanz Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis. |
|
|
Aug 26, 2021 |
422 |
| Pfizer wins European approval for XELJANZ for treatment of juvenile idiopathic arthritis and juvenile psoriatic arthritis. |
|
|
Aug 23, 2021 |
243 |
| Pfizer wins European approval for XELJANZ for treatment of juvenile idiopathic arthritis and juvenile psoriatic arthritis. |
|
|
Aug 23, 2021 |
244 |
| Pfizer's XELJANZ receives MAA in the EU. |
|
|
Aug 20, 2021 |
226 |
| Evaluating various radiographic methods of shoulder joint damage in patients with rheumatoid arthritis receiving biological disease-modifying antirheumatic drugs. |
Sugimori, Kazuhito; Matsushita, Isao; Kimura, Tomoatsu |
|
Jul 8, 2021 |
6342 |
| Study shows Pfizer's RA drug benefits COVID-19 patients. |
|
|
Jun 17, 2021 |
152 |
| Study shows Pfizer's RA drug benefits COVID-19 patients. |
|
|
Jun 17, 2021 |
151 |
| bDMARDs retention rate in the biosimilar era: A real-life monocentric study. |
Becciolini, Andrea; Lumetti, Federica; Di Donato, Eleonora; Giordano, Salvatore; Santilli, Daniele; |
|
Apr 1, 2021 |
972 |
| Coronavirus in Scotland: Two drugs could reduce effect of Covid-19 by 40%, study finds; A Scottish-led international study has recommended two drugs to reduce the complications of Covid-19 by up to 40 per cent. |
Elsa Maishman |
|
Mar 11, 2021 |
569 |
| Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs. |
Keskin, Yacar; Nas, Kemal; Kilic, Erkan; Sargin, Betul; Kasman, Sevtap Acer; Alkan, Hakan; Sahin, Ni |
Clinical report |
Mar 1, 2021 |
6184 |
| Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of Xeljanz in Subjects with Rheumatoid Arthritis. |
|
Report |
Jan 27, 2021 |
591 |
| Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis. |
Wei, Wenyang; Lu, Wanpeng; Chen, Xiaolong; Yang, Yunfeng; Zheng, Mengkai |
|
Jan 1, 2021 |
7276 |
| Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis. |
Hu, Qiong-ying; Yuan, Yun; Li, Yu-chen; Yang, Lu-yao; Zhou, Xiang-yu; Xiong, Da-qian; Zhao, Zi-yi |
|
Jan 1, 2021 |
5275 |
| Total Saponins from Nigella glandulifera Seeds Ameliorate Adjuvant-Induced Rheumatoid Arthritis in Rats by Inhibition of an Inflammatory Response and Bone Erosion. |
Zeng, Li; Li, Chenyang; Jiang, Hailun; Chen, Yan; Li, Zhuorong; Xu, Fang; Liu, Rui |
|
Jan 1, 2021 |
6590 |
| Dissecting the Molecular Mechanism of Wang-Bi Capsule in the Treatment of Experimental Rheumatoid Arthritis Based on Synovial Tissue Proteomic Analysis. |
Shu, Haiyang; Shi, Yingjie; Li, Li; Zhao, Ning; Lu, Cheng; Lu, Aiping; He, Xiaojuan |
|
Jan 1, 2021 |
6921 |
| Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control. |
Velikova, Tsvetelina V.; Kabakchieva, Plamena P.; Assyov, Yavor S.; Georgiev, Tsvetoslav А. |
Clinical report |
Jan 1, 2021 |
10105 |
| Disease-modifying antirheumatic drug prescription patterns in adult rheumatoid arthritis patients in routine clinical practice in Spain. |
Cruz, Blanca Hernandez; Garnica, Inmaculada Urena; Parera, Ricardo Sanchez; Romero, Esteban Rubio; G |
Report |
Oct 1, 2020 |
6673 |
| UK patient receives experimental arthritis drug in trial for severe coronavirus; Farhan Hamid has received a dose of otilimab -a potential rheumatoid arthritis treatment -as well as standard coronavirus care at Manchester Royal Infirmary. |
By, Nilima Marshall & Ryan Merrifield |
|
Sep 28, 2020 |
542 |
| Gilead and Eisai announce Japanese approval of Jyseleca rheumatoid arthritis treatment. |
|
|
Sep 25, 2020 |
184 |
| Gilead and Eisai announce Japanese approval of Jyseleca rheumatoid arthritis treatment. |
|
|
Sep 25, 2020 |
180 |
| Demodex Species Frequency and Risk Factors in Patients With Rheumatoid Arthritis. |
Yazisiz, Hatice; Cekin, Yesim; Sezer, Ilhan; Bostan, Feyzi; Koclar, Fatma Gulsum |
|
Sep 1, 2020 |
5162 |
| Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis. |
Erol, Kemal; Ertas, Ragip |
|
Sep 1, 2020 |
1313 |
| Inhibition of Rheumatoid Arthritis Using Bark, Leaf, and Male Flower Extracts of Eucommia ulmoides. |
Xing, Yun-Yun; Wang, Jian-Ying; Wang, Kai; Zhang, Yan; Liu, Kun; Chen, Xiao-Yun; Yuan, Ying |
|
Aug 31, 2020 |
5338 |
| The Derivative of Tripterygium wilfordii Hook F--Kunxian Capsule, Attenuated Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. |
Liu, Ya-Fei; Zhang, Zhe; Zhang, Jun-Jun; Chen, Zhe; Tu, Sheng-Hao; Xing, Guo-Lan |
|
Aug 31, 2020 |
9326 |
| Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis. |
Ren, Conglin; Li, Mingshuang; Du, Weibin; Lu, Jianlan; Zheng, Yang; Xu, Haipeng; Quan, Renfu |
Report |
Aug 31, 2020 |
5244 |
| Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. |
Haslak, Fatih; Yildiz, Mehmet; Adrovic, Amra; Barut, Kenan; Kasapcopur, Ozgur |
|
Aug 1, 2020 |
3721 |
| Trends in Opioid Use in a Cohort of Patients with Rheumatoid Arthritis. |
Machado-Duque, Manuel E.; Ramirez-Valencia, Diana Marcela; Murillo-Munoz, Maria Monica; Machado-Alba |
|
Jul 31, 2020 |
4303 |
| Clinical profile and treatment outcomes of patients with rheumatoid arthritis at a tertiary care hospital of Pakistan. |
Khaliq, Taqdees; Khan, Asfandyar; Malik, Iftikhar Ahmed |
Report |
Jul 14, 2020 |
3397 |
| The Successful Use of Infliximab in a Relapsing Case of Susac's Syndrome. |
Fernando, Suran L.; Boyle, Therese; Smith, Annika; Parratt, John D.E. |
|
Jun 30, 2020 |
3650 |
| Modified Si-Miao Pill for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. |
Wang, Hui; Huang, Yao; Shen, Pan; Wang, Yu; Qin, Kai; Huang, Ying; Ba, Xin; Lin, Weiji; Chen, Zhe; T |
|
Jun 30, 2020 |
8724 |
| Revive Therapeutics files pre-CTA meeting request with Health Canada to treat the coronavirus with its rheumatoid arthritis therapy. |
|
Clinical report |
Jun 4, 2020 |
668 |
| Concomitant Autoimmune Diseases in Patients With Sarcoidosis in Turkey. |
Yildiz, Fidan; Kobak, Senol; Semiz, Huseyin; Orman, Mehmet |
|
Jun 1, 2020 |
2407 |
| Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future. |
Tu, Jiajie; Wang, Xinming; Gong, Xun; Hong, Wenming; Han, Dafei; Fang, Yilong; Guo, Yawei; Wei, Wei |
|
Apr 30, 2020 |
5651 |
| Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. |
Xing, Qi; Fu, Ling; Yu, Zhichao; Zhou, Xueping |
|
Apr 30, 2020 |
13780 |
| Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease. |
Vacchi, Caterina; Manfredi, Andreina; Cassone, Giulia; Salvarani, Carlo; Cerri, Stefania; Sebastiani |
|
Mar 31, 2020 |
2175 |
| Role of Secreted Frizzled-Related Protein 1 and Tumor Necrosis Factor-[alpha] (TNF-[alpha]) in Bone Loss of Patients with Rheumatoid Arthritis. |
Ginting, Andi Raga; Hidayat, Rudy; Sumariyono, Sumariyono; Koesnoe, Sukamto |
|
Mar 31, 2020 |
5229 |
| Rheumatoid Arthritis Research in the 21st Century: Limitations of Traditional Models, New Technologies, and Opportunities for a Human Biology-Based Approach. |
Cassotta, Manuela; Pistollato, Francesca; Battino, Maurizio |
|
Mar 22, 2020 |
16720 |
| Can-Fite to Release Data Phase III Rheumatoid Arthritis Study with Piclidenoson in Q4. |
|
|
Mar 6, 2020 |
504 |
| Can-Fite Completes 50% Patient Enrollment in Phase III Rheumatoid Arthritis Study and Implements Interim Analysis. |
|
|
Feb 5, 2020 |
595 |
| Control of rheumatoid arthritis with conventional disease-modifying antirheumatic drugs in a tertiary hospital in central South Africa. |
Carter, R.M.N.; van Rensburg, B.J.Jansen; Joubert, G. |
|
Jan 1, 2020 |
4165 |
| Effect of Jiawei Fengshining on Synovial Cell Apoptosis and TGF-[beta]1/Smad Signaling Pathway in Rats with Rheumatoid Arthritis. |
Dong, Xiaojun; Gan, Yuan; Ding, Lina; Zeng, Fujia; Ding, Dou |
|
Dec 31, 2019 |
5817 |
| Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis. |
Huang, Hua; Cen, Han; Zhou, Li; Wang, Ting-hui; Qin, Wen; Xie, Bin-hua; Xiao, Dong-mei; Wu, Xiu-di; |
Clinical report |
Dec 1, 2019 |
4843 |
| Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis. |
Meyer, Pieter W.A.; Ally, Mahmood M.T.M.; Tikly, Mohammed; Tintinger, Gregory; Winchow, Lai Ling; St |
|
Nov 30, 2019 |
4294 |
| Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes. |
Lin, Jin; Yu, Ye; Wang, Xuanwei; Ke, Yini; Sun, Chuanyin; Yue, Lihuan; Xu, Guanhua; Xu, Bei; Xu, Liq |
|
Nov 30, 2019 |
5542 |
| Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial. |
Wen, Hong-Yan; Wang, Jia; Zhang, Sheng-Xiao; Luo, Jing; Zhao, Xiang-Cong; Zhang, Chen; Wang, Cai-Hon |
|
Nov 30, 2019 |
4875 |
| Celltrion Healthcare clears European Commission approval for Remsima SC to treat rheumatoid arthritis. |
|
|
Nov 26, 2019 |
253 |
| Celltrion Healthcare clears European Commission approval for Remsima SC to treat rheumatoid arthritis. |
|
|
Nov 26, 2019 |
249 |
| eWellness Healthcare developing new rheumatoid arthritis treatment platform RA360. |
|
|
Nov 13, 2019 |
350 |
| Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis. |
Kisaarslan, Aysenur Pac; Sozeri, Betul; Gunduz, Zubeyde; Zararsiz, Gokmen; Poyrazoglu, Hakan; Dusuns |
|
Sep 1, 2019 |
4297 |
| Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis. |
Kawashiri, Shin-Ya; Iwamoto, Naoki; Ohba, Kojiro; Kawakami, Atsushi |
|
Aug 31, 2019 |
1384 |
| Astellas Pharma Inc. - Launch of Smyraf[R] Tablets - Provides a new therapeutic option for rheumatoid arthritis in patients who have an inadequate response to conventional therapies -- 10/7/2019. |
|
|
Jul 16, 2019 |
189 |
| CEL-SCI Collaborators Presents Data for New Vaccine in the Treatment of Rheumatoid Arthritis at the International Conference on Immunity and Immunochemistry Meeting. |
|
Conference news |
Jul 11, 2019 |
755 |
| GlaxoSmithKline (LSE: GSK) - GSK announces phase III start for its anti GM-CSF antibody, otilimab, in patients with rheumatoid arthritis (RA) -- 3/7/2019. |
|
|
Jul 9, 2019 |
411 |
| GlaxoSmithKline (LSE: GSK) - GSK announces phase III start for its anti GM-CSF antibody, otilimab, in patients with rheumatoid arthritis (RA) -- 3/7/2019. |
|
|
Jul 4, 2019 |
411 |
| Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis. |
Gutierrez, Maria J.; Desiderio, Stephen V.; Wang, Nae-Yuh; Darrah, Erika; Cappelli, Laura; Nino, Gus |
|
May 31, 2019 |
7088 |
| A Network Pharmacology Study on the Active Ingredients and Potential Targets of Tripterygium wilfordii Hook for Treatment of Rheumatoid Arthritis. |
Hu, Wei; Fu, Wanjin; Wei, Xin; Yang, Yang; Lu, Chao; Liu, Zeyuan |
Report |
Apr 30, 2019 |
8457 |
| Early diagnosis and treatment of rheumatoid arthritis will prevent structural damage-Prof. Kamran Hameed. |
|
|
Apr 30, 2019 |
1466 |
| Using data to reduce negative drug interactions. |
Pearson, Dane; Moy, Brian |
|
Apr 29, 2019 |
896 |
| Surgical Treatment of Juvenile Idiopathic Arthritis A Review. |
Mitrogiannis, Leonidas; Barbouti, Alexandra; Theodorou, Evangelos; Kitsouli, Aikaterini; Mitrogianni |
Disease/Disorder overview |
Apr 1, 2019 |
11842 |
| Prescribing Trend of Antirheumatic Drugs in Taiwan and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study. |
Lee, Chien-Ying; Tai, Chih-Jaan; Tsai, Ya-Fang; Kuan, Yu-Hsiang; Lee, Chiu- Hsiang; Huang, Kuang-Hua |
Report |
Mar 31, 2019 |
5477 |
| Simiao Pill Attenuates Collagen-Induced Arthritis in Rats through Suppressing the ATX-LPA and MAPK Signalling Pathways. |
Shen, Pan; Tu, Shenghao; Wang, Hui; Qin, Kai; Chen, Zhe |
|
Mar 31, 2019 |
6343 |
| A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis. |
Polak, Pavol; Peric, Porin; Louw, Ingrid; Gaylord, Stefanie M.; Williams, Theresa; Becker, Jean-Clau |
Report |
Mar 1, 2019 |
5119 |
| Novel Drug Delivery Systems for Rheumatoid Arthritis: An Approach to Better Patient Compliance. |
Mohanty, Sangeeta; Panda, Sthitapragnya; Bhanja, Aslesha; Pal, Abhisek; Si, Sudam Chandra |
|
Mar 1, 2019 |
5294 |
| Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression. |
Yayikci, Yakup Ilker; Karadag, Ahmet |
|
Feb 1, 2019 |
4034 |
| Genentech announces FDA approval for ACTPen autoinjector for Actemra. |
|
|
Nov 26, 2018 |
406 |
| Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis. |
Li, Zhan-Guo; Liu, Yi; Xu, Hu-Ji; Chen, Zhi-Wei; Bao, Chun-De; Gu, Jie-Ruo; Zhao, Dong-Bao; An, Yuan |
Report |
Nov 20, 2018 |
6257 |
| Vitamin D. |
|
|
Sep 1, 2018 |
364 |
| Eli Lilly and Company & Incyte pass US FDA approval for 2-mg dose of OLUMIANT for treating rheumatoid arthritis. |
|
|
Jun 4, 2018 |
310 |
| Eli Lilly and Company & Incyte pass US FDA approval for 2-mg dose of OLUMIANT for treating rheumatoid arthritis. |
|
|
Jun 4, 2018 |
306 |
| A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment. |
Miwa, Yusuke; Ikari, Yuzo; Hosonuma, Masahiro; Hatano, Mika; Hayashi, Tomoki; Kasama, Tsuyoshi; Sana |
|
Jun 1, 2018 |
2925 |
| Before the Move: Nomura worries about Incyte's RA drug after 'ominous' docs. |
|
|
Apr 20, 2018 |
773 |
| Profile of spending on the treatment of rheumatoid arthritis for patients of the Unified Health System in the state of Minas Gerais--2008-2013/ Perfil de gastos com o tratamento da Artrite Reumatoide para pacientes do Sistema Unico de Saude em Minas Gerais, Brasil, de 2008 a 2013. |
da Silva, Grazielle Dias; Andrade, Eli Iola Gurgel; Cherchiglia, Mariangela Leal; Almeida, Alessandr |
|
Apr 1, 2018 |
8437 |
| ARTHRITIS DRUGS 'HELP CUT RISK OF DEVELOPING DEMENTIA'. |
|
|
Feb 13, 2018 |
301 |
| Dementia risk halved by 10p pill for arthritis; Drug hope for patients who suffer chronic pain. |
|
|
Feb 13, 2018 |
160 |
| Anika Therapeutics and Institute for Applied Life Sciences at UMAss Amherst Expand Collaboration to Develop Rheumatoid Arthritis Treatment. |
|
|
Jan 29, 2018 |
232 |
| Endobronchial Watanabe Spigots for Treatment of Pyopneumothorax due to Nontuberculous Mycobacteriosis in a Patient with Rheumatoid Arthritis: A Case Report Based on Past Experience. |
Kawai, Norikazu; Kawaguchi, Takeshi; Tojo, Takashi; Osa, Takao; Yamamoto, Yoshifumi; Yasukawa, Motoa |
|
Jan 1, 2018 |
1664 |
| Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus. |
Caporali, R.; Doria, A.; Ferraccioli, G.F.; Meroni, P.L.; Zavaglia, D.; Iannone, F. |
|
Jan 1, 2018 |
5395 |
| The Management of Acute Anterior Uveitis Complicating Spondylarthritis: Present and Future. |
Biggioggero, Martina; Crotti, Chiara; Becciolini, Andrea; Miserocchi, Elisabetta; Favalli, Ennio Giu |
|
Jan 1, 2018 |
8956 |
| Pharmacologic Effect of Miao Medicine Illicium simonsii Maxim. on Collagen-Induced Arthritis in Rats. |
Zhang, Qing-zhong; Hu, Xian-yun; Yao, Wen-qin; Wan, Xiao-li; Liang, Zi-cong; Dang, Rong-min; Yang, Z |
|
Jan 1, 2018 |
4664 |
| A Systematic Review about the Efficacy and Safety of Tripterygium wilfordii Hook.f. Preparations Used for the Management of Rheumatoid Arthritis. |
Wang, Jing; Chen, Na; Fang, Liang; Feng, Zhe; Li, Guochun; Mucelli, Attilio; Zhang, Xu; Zhou, Xuepin |
|
Jan 1, 2018 |
9265 |
| K Nearest Neighbor Algorithm Coupled with Metabonomics to Study the Therapeutic Mechanism of Sendeng-4 in Adjuvant-Induced Rheumatoid Arthritis Rat. |
Wang, Xiye; Li, Dan; Jiang, Mingyang; Pei, Zhili; Xu, Liang |
|
Jan 1, 2018 |
5828 |
| Pfizer receives US FDA approval for psoriatic arthritis drugs Xeljanz and Xeljanz XR. |
|
|
Dec 18, 2017 |
226 |
| Pfizer receives US FDA approval for psoriatic arthritis drugs Xeljanz and Xeljanz XR. |
|
|
Dec 18, 2017 |
222 |
| FDA Approves Xeljanz (tofacitinib) and Xeljanz XR for Treatment of Active Psoriatic Arthritis. |
|
|
Dec 18, 2017 |
402 |
| USFDA approves Pfizer's IXIFI. |
|
|
Dec 15, 2017 |
116 |
| USFDA approves Pfizer's IXIFI. |
|
|
Dec 15, 2017 |
112 |
| Injection Of Mesenchymal Precursor Cells Shown Safe, Tolerable Among RA Patients. |
|
|
Nov 20, 2017 |
567 |
| Injection Of Mesenchymal Precursor Cells Shown Safe, Tolerable Among RA Patients. |
|
|
Nov 13, 2017 |
566 |
| Injection Of Mesenchymal Precursor Cells Shown Safe, Tolerable Among RA Patients. |
|
|
Nov 13, 2017 |
567 |
| Successfully Managing Rheumatoid Arthritis: Medication and a healthy lifestyle can help ease the pain, stiffness, and other symptoms of RA. |
|
|
Nov 1, 2017 |
747 |
| Delayed conventional DMARDs therapy is effective in Rheumatoid Arthritis. |
|
Clinical report |
Aug 31, 2017 |
2521 |
| Lilly & Incyte partnership to file Baricitinib Resubmission for the treatment of rheumatoid arthritis with US FDA. |
|
|
Aug 31, 2017 |
272 |
| Lilly & Incyte partnership to file Baricitinib Resubmission for the treatment of rheumatoid arthritis with US FDA. |
|
|
Aug 31, 2017 |
268 |
| Treatment of rheumatoid arthritis with biological agents --as a typical and common immune-mediated inflammatory disease. |
Takeuchi, Tsutomu |
Report |
Aug 1, 2017 |
4614 |
| Pesticide exposure and risk of rheumatoid arthritis among licensed male pesticide applicators in the agricultural health study. |
Meyer, Armando; Sandler, Dale P.; Freeman, Laura E. Beane; Hofmann, Jonathan N.; Parks, Christine G. |
Report |
Jul 1, 2017 |
8754 |
| RHEUMATOID ARTHRITIS THERAPIES: PRESENT AND FUTURE. |
|
|
Jun 30, 2017 |
3019 |
| Sanofi, Regeneron cleared to market Kevzara. |
|
|
Jun 5, 2017 |
103 |
| Diplomat to distribute KEVZARA in the US for treatment of rheumatoid arthritis. |
|
Disease/Disorder overview |
May 26, 2017 |
207 |
| Diplomat to distribute KEVZARA in the US for treatment of rheumatoid arthritis. |
|
Disease/Disorder overview |
May 26, 2017 |
211 |
| Sanofi and Regeneron's Kevzara(R) (sarilumab) gains FDA approval for Rheumatoid Arthritis treatment. |
|
|
May 23, 2017 |
262 |
| Sanofi and Regeneron's Kevzara(R) (sarilumab) gains FDA approval for Rheumatoid Arthritis treatment. |
|
|
May 23, 2017 |
258 |
| Sanofi and Regeneron's sarilumab granted US FDA approval. |
|
|
May 23, 2017 |
220 |
| Sanofi and Regeneron's sarilumab granted US FDA approval. |
|
|
May 23, 2017 |
216 |
| STUDY OF ERYTHROCYTE SEDIMENTATION RATE AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN RHEUMATOID ARTHRITIS. |
|
|
Apr 30, 2017 |
2318 |
| Regeneron and Sanofi report encouraging opinion from CHMP for Kevzara to treat rheumatoid arthritis. |
|
|
Apr 24, 2017 |
285 |
| Regeneron and Sanofi report encouraging opinion from CHMP for Kevzara to treat rheumatoid arthritis. |
|
|
Apr 24, 2017 |
281 |
| Taking TNFis may help lower heart attack risk in people with rheumatoid arthritis. |
|
|
Apr 1, 2017 |
196 |
| Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy. |
Evangelista, Perry J.; Evangelista, Gregory T.; Ogrich, Lauren M. |
Clinical report |
Apr 1, 2017 |
2359 |
| Pfizer's XELJANZ Rheumatoid Arthritis drug gains EU marketing authorisation. |
|
|
Mar 28, 2017 |
282 |
| Pfizer's XELJANZ Rheumatoid Arthritis drug gains EU marketing authorisation. |
|
|
Mar 28, 2017 |
278 |
| European Union Grants Pfizer Marketing Authorisation for Xeljianz to Treat Rheumatoid Arthritis. |
|
|
Mar 27, 2017 |
445 |
| China FDA Approves Pfizer's Xeljanz Oral JAK Inhibitor for Rheumatoid Arthritis. |
|
|
Mar 17, 2017 |
343 |
| Prevalence of metabolic syndrome in treatment naive rheumatoid arthritis and correlation with disease parameters. |
Pandey, Purneshwar Kumar; Swami, Abhijit; Biswas, Tanuj Kumar; Thakuria, Riturag |
Clinical report |
Mar 1, 2017 |
3866 |
| Eli Lilly and Company & Incyte partnership awarded marketing authorisation for Olumiant for the treatment of rheumatoid arthritis in the EU. |
|
|
Feb 14, 2017 |
310 |
| Eli Lilly and Company & Incyte partnership awarded marketing authorisation for Olumiant for the treatment of rheumatoid arthritis in the EU. |
|
|
Feb 14, 2017 |
306 |
| Lilly Wins EC Nod for Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis. |
|
|
Feb 14, 2017 |
437 |
| Regeneron & Sanofi partnership wins first approval of Kevzara for treating rheumatoid arthritis in Canada. |
|
|
Feb 1, 2017 |
279 |
| Regeneron & Sanofi partnership wins first approval of Kevzara for treating rheumatoid arthritis in Canada. |
|
|
Feb 1, 2017 |
275 |
| JAK inhibitor achieves results similar to adalimumab for psoriatic arthritis. |
Goodman, Alice |
|
Feb 1, 2017 |
646 |
| A Case of Initially Undiagnosed Chikungunya Arthritis Developing into Chronic Phase in a Nonendemic Area. |
Chan, Pui Shan Julia; Leung, Moon Ho |
Case study |
Jan 1, 2017 |
1684 |
| Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis. |
Bergrath, Evelien; Gerber, Robert A.; Gruben, David; Lukic, Tatjana; Makin, Charles; Wallenstein, Ge |
Report |
Jan 1, 2017 |
10565 |
| Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. |
Rigby, William F.C.; Lampl, Kathy; Low, Jason M.; Furst, Daniel E. |
Report |
Jan 1, 2017 |
11419 |
| The Impacts of Chrysanthemum indicum Extract on Oxidative Stress and Inflammatory Responses in Adjuvant-Induced Arthritic Rats. |
Dong, Mei; Yu, Dongsheng; Dhabi, Naif Abdullah Al-; Duraipandiyan, Veeramuthu |
Report |
Jan 1, 2017 |
4570 |
| Astilbin from Smilax glabra Roxb. Attenuates Inflammatory Responses in Complete Freund's Adjuvant-Induced Arthritis Rats. |
Dong, Lisha; Zhu, Jinqiu; Du, Hongzhi; Nong, Heng; He, Xicheng; Chen, Xiaoyu |
|
Jan 1, 2017 |
6083 |
| Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics. |
Akiyama, Mitsuhiro; Kaneko, Yuko; Takeuchi, Tsutomu |
Report |
Jan 1, 2017 |
3529 |
| No significant increase in newborn infections, after prenatal TNFi exposure. |
Sullivan, Michele G. |
|
Jan 1, 2017 |
743 |
| Bones & joints newsbriefs. |
|
|
Jan 1, 2017 |
194 |
| Should patients with "low disease activity" rheumatoid arthritis stop using tumor necrosis factor inhibitor drugs? New evidence provides more information to help physicians and patients make the decision. |
|
|
Dec 1, 2016 |
615 |
| Analysis of color in the CIELAB space in time for the inside of the Annona Muricata contaminated with malathion. |
Palacios, Angelica; Moreno, Fernando; Amaya, Dario |
Report |
Dec 1, 2016 |
2380 |
| Frequency of metabolic syndrome in Pakistani cohort of patients with rheumatoid arthritis. |
|
|
Jun 30, 2016 |
4174 |
| Are we able to suppress disease activity adequately in patients with established rheumatoid arthritis? An observational and cross-sectional study. |
Sengul, Ilker; Yalbuzdag, Seniz Akcay; Ince, Bugra; Karatepe, Altinay Goksel; Kaya, Taciser |
Report |
Jun 1, 2016 |
3415 |
| Vitamin K2 shows promise as rheumatoid arthritis treatment. |
|
Brief article |
Apr 1, 2016 |
199 |
| Step therapy and biologics: an easier road ahead? |
Smith, Jennie |
|
Mar 1, 2016 |
1947 |
| Fish oil for rheumatoid arthritis. |
Gaby, Alan R. |
Author abstract |
Feb 1, 2016 |
257 |
| Assessment of the Therapeutic Effect of Total Glucosides of Peony for Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis. |
Cai, Yongsong; Yuan, Qiling; Xu, Ke; Zhu, Jialin; Li, Yuanbo; Wu, Xiaoqing; Yang, Le; Qiu, Yusheng; |
|
Jan 1, 2016 |
9532 |
| Eisai and Toyama Chemical Clear All-Case Surveillance Condition for Approval of Antirheumatic Agent Iguratimod. |
|
|
Dec 1, 2015 |
963 |
| Infections in the management of rheumatic diseases: an update. |
Botha-Scheepers, S.A.; Sarembock, B. |
|
Dec 1, 2015 |
3702 |
| Turkish compliance and adaptation of EULAR 2013 recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: expert opinion of TLAR. |
Ataman, Sebnem; Surmeli, Zuhre Sari; Sunar, Ismihan; Ozdemirel, Erhan; Akinci, Aysen; Bodur, Hatice; |
|
Dec 1, 2015 |
9515 |
| Rheumatic diseases and their treatment with anti-rheumatic drugs during pregnancy/Gebelik doneminde romatizmal hastaliklar ve antiromatizmal ilac kullanimi. |
Borman, Pinar; Ozdemir, Oya |
Report |
Dec 1, 2015 |
5568 |
| Comparison of glucocorticoid and nonsteroidal anti-inflammatory drug requirement before and after tumor necrosis factor inhibitor treatment in patients with rheumatoid arthritis. |
Birlik, Merih; Capar, Sedat; Akar, Servet; Sari, Ismail; Onen, Fatos; Akkoc, Nurullah |
|
Sep 1, 2015 |
4266 |
| Polish rheumatologists and rheumatoid arthritis patients differ in their opinions about treatment inefficacy. |
Raczkiewicz, Anna; Juszkiewicz, Aleksandra; Tlustochowicz, Malgorzata; Tlustochowicz, Witold |
|
Sep 1, 2015 |
3548 |
| Age drives miscarriage risk in rheumatoid arthritis patients. |
Wendling, Patrice |
Clinical report |
Aug 1, 2015 |
563 |
| Improvement thresholds for morning stiffness duration in patients receiving delayed-versus immediate-release prednisone for rheumatoid arthritis. |
Buttgereit, Frank; Kent, Jeffrey D.; Holt, Robert J.; Grahn, Amy Y.; Rice, Patricia; Alten, Rieke; Y |
Report |
Jul 1, 2015 |
6797 |
| Rheumatoid arthritis clinical features and management strategies at an urban tertiary facility in Pakistan. |
|
|
Dec 31, 2014 |
2256 |
| DMARDS, steroids alone did not elevate preterm birth risk. |
London, Susan |
|
Oct 1, 2014 |
374 |
| Periprosthetic joint infection in patients receiving TNF[alpha] antagonists. |
Snir, Nimrod; Schwarzkopf, Ran; Sobieraj, Michael; Lovy, Andrew J.; Slover, James D. |
Report |
Oct 1, 2014 |
4300 |
| The Balancing Act[R] Airing on Lifetime[R] Talks Rheumatoid Arthritis Relief and Sauerkraut Benefits. |
|
|
May 1, 2014 |
475 |
| Angioedema as a prodrome of rheumatoid arthritis exacerbation. |
Desai, Ketan |
Clinical report |
Apr 1, 2014 |
1163 |
| Three providers dominate the specialty Rx sector. |
|
|
Mar 17, 2014 |
202 |
| Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. |
Villafradez-Diaz, Magaly; Santiago-Casas, Yesenia; Nieves-Plaza, Mariely; Morales, Myraida; Rodrigue |
|
Mar 1, 2014 |
4725 |
| Potential relief for rheumatoid arthritis sufferers. |
|
|
Mar 1, 2014 |
181 |
| VitaBreeze Announces They Will Donate Proceeds to Support Rheumatoid Awareness Day. |
|
|
Feb 2, 2014 |
350 |
| Anncaliia algerae microsporidial myositis. |
Watts, Matthew R.; Chan, Renee C.F.; Cheong, Elaine Y.L.; Brammah, Susan; Clezy, Kate R.; Tong, Chiw |
Author abstract |
Feb 1, 2014 |
5435 |
| Certain gut bacteria linked to rheumatoid arthritis: "Linked" doesn't mean causal, but new findings may point the way to new treatment targets and techniques. |
Pisetsky, David S. |
|
Jan 1, 2014 |
918 |
| RA drugs lower the risk of heart attack. |
|
|
Jan 1, 2014 |
167 |
| JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. |
Hsu, Leeyen; Armstrong, April W. |
Report |
Jan 1, 2014 |
5582 |
| Clinical prediction rule identifies risk for RA. |
Nellist, Catherine Cooper |
|
Nov 15, 2013 |
635 |
| Genentech's subcutaneous formulation of Actemra approved by US FDA. |
|
|
Oct 22, 2013 |
249 |
| Genentech's subcutaneous formulation of Actemra approved by US FDA. |
|
|
Oct 22, 2013 |
245 |
| Market Report, "Rheumatoid Arthritis - Pipeline Review, H2 2013", published. |
|
|
Oct 18, 2013 |
1034 |
| Paid Rheumatoid Arthritis (RA) Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with RA Age 18 - 75. |
|
|
Oct 16, 2013 |
725 |
| Expert urges careful use of diagnostic criteria for ra. |
Jancin, bruce |
|
Sep 15, 2013 |
750 |
| The reported adverse effects related to biological agents used for the treatment of rheumatic diseases in Turkey / Romatizmal Hastaliklarin Tedavisinde Biyolojik Ajanlarin Kullanimina Bagli Turkiye'de Bildirilmis Yan Etkiler. |
Kilic, Erkan; Kilic, Gamze; Akgul, Ozgur; Akgol, Gurkan; Ozgocmen, Salih |
|
Sep 1, 2013 |
9551 |
| Vogt-koyanagi-harada disease associated with rheumatoid arthritis / Romatoid Artrit ile Ilickili Vogt-Koyanagi-Harada Hastaligi. |
Tufan, Hasan Ali; Akbal, Ayla; Arikan, Sedat; Gencer, Baran; Kara, Selcuk; Tufan, Abdurrahman |
|
Sep 1, 2013 |
1849 |
| DPP-4 inhibition in diabetic rheumatoid arthritis patients: Diabetik Romatoid Artrith Hastalarda DPP-4 inhibisyonu. |
Pamuk, Baris |
Letter to the editor |
Sep 1, 2013 |
945 |
| Arthritis at advanced age: rheumatoid arthritis and differential diagnosis/Ileri yasta artrit: romatoid artrit ve ayina tanisi. |
Ergin, Emine Sureyya; Kibar, Sibel |
Report |
Sep 1, 2013 |
6522 |
| An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. |
Sun, Peijiao; Liu, Yonggang; Deng, Xiaoxia; Yu, Chunmei; Dai, Nasang; Yuan, Xianglian; Chen, Liping; |
Report |
Aug 15, 2013 |
3829 |
| South African recommendations for the management of rheumatoid arthritis: an algorithm for the standard of care in 2013. |
Hodkinson, B.; van Duuren, E.; Pettipher, C.; Kalla, A.A. |
|
Aug 1, 2013 |
9827 |
| Pfizera[euro](tm)s XELJANZ (tofacitinib citrate) approved in Switzerland for Rheumatoid Arthritis treatment and also in other countries. |
|
|
Jul 16, 2013 |
389 |
| Pfizera[euro](tm)s XELJANZ (tofacitinib citrate) approved in Switzerland for Rheumatoid Arthritis treatment and also in other countries. |
|
|
Jul 16, 2013 |
385 |
| Pfizer Inc updates global regulatory approvals and launches of XELJANZ for treating rheumatoid arthritis. |
|
|
Jul 15, 2013 |
298 |
| Pfizer Inc updates global regulatory approvals and launches of XELJANZ for treating rheumatoid arthritis. |
|
|
Jul 15, 2013 |
294 |
| Juvenile idiopathic arthritis: what the clinician needs to know. |
Kahn, Philip J. |
Disease/Disorder overview |
Jul 1, 2013 |
4010 |
| Immunogenicity: implications for rheumatoid arthritis treatment. |
Solomon, Gary |
Report |
Jul 1, 2013 |
2477 |
| Treating to target in rheumatoid arthritis: challenges and opportunities. |
Ruderman, Eric M. |
Report |
Jul 1, 2013 |
2740 |
| Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis. |
|
|
Jun 30, 2013 |
2903 |
| Pain was just part of growing up; The first ever Rheumatoid Arthritis Awareness Week aims to dispel the myth that it only affects older people. Indeed, the painful condition can affect anybody - including children, as Lisa Salmon knows first-hand. |
|
|
Jun 27, 2013 |
1257 |
| Pain was just part of growing up; The first ever Rheumatoid Arthritis Awareness Week aims to dispel the myth that it only affects older people. Indeed, the painful condition can affect anybody - including children, as Lisa Salmon knows first-hand. |
|
|
Jun 27, 2013 |
771 |
| Tyneside scientists to lead on arthritis. |
|
|
Jun 26, 2013 |
652 |
| Rigel takes over responsibility for Fostamatinib programme from AstraZeneca. |
|
|
Jun 5, 2013 |
330 |
| Rigel takes over responsibility for Fostamatinib programme from AstraZeneca. |
|
|
Jun 5, 2013 |
326 |
| An overview of late-onset rheumatoid arthritis. |
Evcik, Deniz |
Disease/Disorder overview |
Jun 1, 2013 |
813 |
| Positive Phase 2a study results in refractory rheumatoid arthritis. |
|
|
May 6, 2013 |
344 |
| Positive phase 2a study results in refractory rheumatoid arthritis. |
|
|
May 6, 2013 |
236 |
| New meds combo for rheumatoid arthritis. |
|
|
Apr 1, 2013 |
166 |
| MR elastography of liver disease: State of the art. |
Chen, Jun; Yin, Meng; Glaser, Kevin J.; Talwalkar, Jayant A.; Ehman, Richard L. |
Clinical report |
Apr 1, 2013 |
5485 |
| Pfizer Inc's XELJANZ 5 mg twice daily approved for treating RA adult patients in Japan. |
|
|
Mar 26, 2013 |
212 |
| Melatonin serum levels in rheumatoid arthritis/Romatoid artritte serum melatonin duzeyleri. |
Baykal, Tuba; Senel, Kazim; Melikoglu, Meltem Alkan; Erdal, Akin; Alp, Hamit Hakan; Ugur, Mahir |
Report |
Mar 1, 2013 |
2253 |
| Scientists Improve New Therapy for Rheumatoid Arthritis Treatments. |
|
|
Feb 15, 2013 |
455 |
| Immune system depressant prevents rheumatoid arthritis in mice. |
|
|
Feb 9, 2013 |
302 |
| New drug target for rheumatoid arthritis identified. |
|
|
Jan 26, 2013 |
670 |
| Genes and their regulatory 'tags' that promote rheumatoid arthritis identified. |
|
|
Jan 21, 2013 |
701 |
| Evidence that the strategy is more important than the agent to treat rheumatoid arthritis: data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. |
Pincus, Theodore; Castrejon, Isabel |
Report |
Jan 15, 2013 |
6601 |
| Foreword. |
Yazici, Yusuf |
|
Jan 15, 2013 |
188 |
| Efficacy and safety of iguratimod for the treatment of rheumatoid arthritis. |
Li, Jiangtao; Mao, Hejuan; Liang, Yan; Lu, Yanrong; Chen, Shuo; Yang, Nanping; Shi, Guixiu |
|
Jan 1, 2013 |
11640 |
| Exercise and early treatment can help ease pain of arthritis. |
|
|
Dec 31, 2012 |
263 |
| Astellas Pharma and UCB receive Japanese approval for Cimzia. |
|
|
Dec 27, 2012 |
109 |
| Astellas Pharma and UCB receive Japanese approval for Cimzia. |
|
|
Dec 27, 2012 |
105 |
| Antares Pharma Inc submits OTREXUP's NDA to FDA for treating rheumatoid arthritis. |
|
|
Dec 18, 2012 |
188 |
| Antares Pharma Inc submits OTREXUP's NDA to FDA for treating rheumatoid arthritis. |
|
|
Dec 18, 2012 |
184 |
| Galapagos to test GLPG0634 rheuma drug in US. |
|
|
Dec 4, 2012 |
107 |
| New rheumatoid arthritis drug targets NIH-discovered protein. |
|
Brief article |
Dec 4, 2012 |
131 |
| Risk of rheumatoid arthritis with elevated rheumatoid factor. |
|
|
Dec 1, 2012 |
410 |
| Spondylitis and arthritis in familial Mediterranean fever / Ailesel Akdeniz atesinde spondilit ve artrit. |
Sarikaya, Selda; Ozdolap, Senay; Marasli, Erdem |
Author abstract |
Dec 1, 2012 |
3445 |
| A possible relationship between polymorphisms of glutathione S-transferase M1, P1 and T1 genes and rheumatoid arthritis in Zahedan, Southeast Iran / Guneydogu Iran Zahedan'da glutation S-transferaz M1, P1 ve T1 genlerinin polimorfizmlerive romatoid artrit arasindaki muhtemel iliski. |
Hashemi, Mohammad; Eskandari-Nasab, Ebrahim; Zakeri, Zahra; Atabaki, Mahdi; Rezaei, Hamzeh; Bahari, |
Report |
Dec 1, 2012 |
2472 |
| Chronic recurrent multifocal osteomyelitis: treatment with a tumor necrosis factor-alpha inhibitor / Kronik tekrarlayan multifokal osteomiyelit: tumor nekroz faktor-alfa inhibitoru tedavisi. |
Cavalcanti, Andre de Souza; Sena, Evaldo Gomes; Cavalcanti, Sergio Vasconcelos; Cavalcanti, Fernando |
Report |
Dec 1, 2012 |
2178 |
| Protalex Inc enrols first patient in the US to study PRTX-100 for treating active rheumatoid arthritis. |
|
|
Nov 30, 2012 |
194 |
| Protalex Inc enrols first patient in the US to study PRTX-100 for treating active rheumatoid arthritis. |
|
|
Nov 30, 2012 |
190 |
| Early use of DMARDs can prevent disability from rheumatic diseases - Dr. Mahboobur Rehman. |
|
|
Nov 30, 2012 |
1432 |
| Incyte Corporation receives USD50m milestone payment as baricitinib advances into Phase III for Rheumatoid Arthritis. |
|
|
Nov 16, 2012 |
153 |
| Incyte Corporation receives USD50m milestone payment as baricitinib advances into Phase III for Rheumatoid Arthritis. |
|
|
Nov 16, 2012 |
149 |
| Tofacitinib approved for rheumatoid arthritis. |
Mechcatie, Elizabeth |
|
Nov 15, 2012 |
550 |
| Pfizera[euro](tm)s XELJANZ approved by US FDA for adults with moderately to severely active rheumatoid arthritis. |
|
|
Nov 7, 2012 |
320 |
| Pfizera[euro](tm)s XELJANZ approved by US FDA for adults with moderately to severely active rheumatoid arthritis. |
|
|
Nov 7, 2012 |
306 |
| Legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab. |
Wuerz, Terry C.; Mooney, Owen; Keynan, Yoav |
|
Nov 1, 2012 |
1656 |
| Autoimmune diseases: early diagnosis and new treatment strategies. |
van Venrooij, Walther J.; Lories, Rik; Ward, Michael M. |
|
Nov 1, 2012 |
3021 |
| Danny's PS2m hospital goal; Cash man: Danny with Jan Gardner, a ward manager on the Neonatal surgical ward at Birmingham Children's Hospital. |
|
|
Oct 17, 2012 |
152 |
| Early aggressive intervention is essential to check joint destruction in Rheumatoid Arthritis - Prof. Tasnim Ahsan. |
|
|
Oct 14, 2012 |
1217 |
| 'Humanized' mice may enable discovery of better medicines for rheumatoid arthritis. |
|
|
Oct 5, 2012 |
572 |
| New Phase 2 Rheumatoid Arthritis Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; 35 Locations Throughout the U.S.. |
|
|
Sep 18, 2012 |
830 |
| Sufferers needed to be part of pounds 1m trial. |
|
|
Sep 12, 2012 |
242 |
| Eisai Announces Launch of Anti-Rheumatic Agent Careram(R). |
|
|
Sep 11, 2012 |
534 |
| 'Nobody had actually said to me that I was about to spend the rest of my life in a wheelchair, but it was becoming obvious'. |
|
|
Sep 10, 2012 |
371 |
| Rise in rheumatoid arthritis linked with obesity: early detection and treatment and a healthy lifestyle are crucial for the best prognosis. |
|
|
Sep 1, 2012 |
1105 |
| From pathology to diagnosis: a symptom-free patient with a rheumatoid nodule in the foot / patolojiden taniya: semptomsuz bir hastada ayakta romatoid nodul. |
Tastekin, Ebru; Btrtane, Murat; Kilinc, Serdar; Ciftdemtr, Mert; Usta, Ufuk; Tastekin, Nurettin |
Report |
Sep 1, 2012 |
2250 |
| Posterior interosseous nerve entrapment in a patient with rheumatoid arthritis / Romatoid artritli bir hastada posterior interosseoz sinir tuzaklanmasi. |
Baklaci, Korhan; Ozgul, Ahmet |
|
Sep 1, 2012 |
2345 |
| Rheumatoid arthritis. |
|
Disease/Disorder overview |
Sep 1, 2012 |
6589 |
| Pfizer Inc's NDA for tofacitinib extended by three months. |
|
|
Aug 22, 2012 |
170 |
| Pfizer Inc's NDA for tofacitinib extended by three months. |
|
|
Aug 22, 2012 |
174 |
| Abbott Japan and Eisai Receive Approval to Market the Fully Human Anti-TNF-Alpha Monoclonal Antibody Humira(R). |
|
|
Aug 10, 2012 |
661 |
| Scientists find a potential inhibitor for rheumatoid arthritis development. |
|
|
Aug 1, 2012 |
207 |
| Pfizer Inc gets encouraging top-line results from ORAL Start Phase 3 trial of tofacitinib in rheumatoid arthritis patients. |
|
|
Aug 1, 2012 |
213 |
| Safely manage joint inflammation: curcumin. |
Evans, Susan |
Report |
Aug 1, 2012 |
5087 |
| Moderate drinking lowers risk of rheumatoid arthritis in women. |
|
|
Jul 18, 2012 |
514 |
| Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance. |
Lu, Yue; Xiao, Juan; Wu, Zai-Wang; Wang, Zhe-Ming; Hu, Jia; Fu, Hong-Zheng; Chen, Ying-Yu; Qian, Rui |
Report |
Jul 15, 2012 |
5696 |
| Juvenile idiopathic arthritis: an update for the clinician. |
Kahn, Philip |
Disease/Disorder overview |
Jul 1, 2012 |
11724 |
| MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. |
Pincus, Theodore; Skummer, Philip T.; Grisanti, Michael T.; Castrejon, Isabel; Yazici, Yusuf |
|
Jul 1, 2012 |
5070 |
| Predictors of response to TNF inhibitors in rheumatoid arthritis: do we have new tools for personalized medicine? |
Simsek, Ismail |
|
Jul 1, 2012 |
2842 |
| T-cell agents in the treatment of rheumatoid arthritis: 2012 update. |
Solomon, Gary E. |
|
Jul 1, 2012 |
2643 |
| IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions. |
Woodrick, Robert S.; Ruderman, Eric M. |
|
Jul 1, 2012 |
3587 |
| B-cell therapies for rheumatoid arthritis. |
Scher, Jose U. |
|
Jul 1, 2012 |
2975 |
| Top 20 pharma report. |
|
Company overview |
Jul 1, 2012 |
26004 |
| Effects of oral administration of type II collagen on rheumatoid arthritis. |
|
Brief article |
Jul 1, 2012 |
135 |
| A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. |
|
Brief article |
Jul 1, 2012 |
167 |
| A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. |
|
Author abstract |
Jul 1, 2012 |
408 |
| ChemoCentryx Reports Positive Phase 2 Data with CCX354,. |
|
|
Jul 1, 2012 |
861 |
| Abbott Announces 10-Year Data Evaluating HUMIRA. |
|
|
Jul 1, 2012 |
1595 |
| Eisai and Toyama Chemical Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan. |
|
|
Jun 29, 2012 |
470 |
| R&D projects take aim at arthritis. |
|
|
Jun 11, 2012 |
621 |
| asktheDoc. |
|
|
Jun 5, 2012 |
168 |
| BCM-95 curcumin as effective as prescription drug in rheumatoid arthritis. |
|
Clinical report |
Jun 1, 2012 |
194 |
| Anemia of chronic disease in ankylosing spondylitis: improvement following anti-TNF therapy / ankilozan spondilitte kronik anemi hastaligi / anti-TNF tedavisini takiben iyilesme. |
Kim, Ki-Jo; Cho, Chul-Soo |
|
Jun 1, 2012 |
4365 |
| Follow-up results of our patients with rheumatoid arthritis / romatoid artritli hastalarimizin takip sonuclari. |
Yalcin, Tugba; Bal, Ajda; Dulgeroglu, Deniz; Cakci, Aytul |
Report |
Jun 1, 2012 |
6263 |
| VQ OrthoCare[R] Announces New Treatment Option for Rheumatoid Arthritis. |
|
|
May 24, 2012 |
541 |
| New target to battle rheumatoid arthritis identified. |
|
|
May 21, 2012 |
589 |
| Panel recommends tofacitinib approval for refractory RA. |
Tucker, Miriam E. |
|
May 15, 2012 |
708 |
| Galapagos announces initiation of Phase IIa study with GLPG0634. |
|
Clinical report |
May 14, 2012 |
269 |
| Galapagos begins Phase IIa study with GLPG0634. |
|
|
May 14, 2012 |
278 |
| Pfizer Inc announces US FDA Arthritis Advisory Committee's recommendation of Tofacitinib for active rheumatoid arthritis. |
|
|
May 10, 2012 |
213 |
| Entia Biosciences Inc unveils ErgoD2 Flex-RA medical food for Rheumatoid Arthritis. |
|
|
May 3, 2012 |
157 |
| Anemia triples infection risk with biologics. |
London, Susan |
|
May 1, 2012 |
601 |
| Psoriatic arthritis: biologies seen as new treatment: more aggressive treatment is recommended for psoriatic arthritis, a severe, progressive form of the disease. |
Keenan, Robert T. |
|
Apr 1, 2012 |
632 |
| An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. |
Pincus, Theodore; Castrejon, Isabel |
Report |
Apr 1, 2012 |
9164 |
| Beware of registries for their biases. |
Yazici, Hasan |
Report |
Apr 1, 2012 |
2490 |
| Psoriatic arthritis's pathogenesis differs widely from RA's. |
Jancin, Bruce |
|
Mar 15, 2012 |
928 |
| Atrial fibrillation, stroke risks elevated in RA. |
Splete, Heidi |
|
Mar 15, 2012 |
551 |
| A-fib, stroke risks rise in rheumatoid arthritis. |
Splete, Heidi |
|
Mar 15, 2012 |
469 |
| Glucocorticoid injections controlled early RA. |
Worcester, Sharon |
|
Mar 15, 2012 |
952 |
| TNF inhibitors didn't increase zoster risk. |
Jancin, Bruce |
|
Mar 15, 2012 |
819 |
| Biologic users mycobacterial lung infection. |
Jancin, Bruce |
|
Mar 1, 2012 |
792 |
| TNF inhibitors did not raise risk of zoster in large study. |
Jancin, Bruce |
Clinical report |
Mar 1, 2012 |
686 |
| Biologies' lowered infection risk questioned. |
Jancin, Bruce |
|
Mar 1, 2012 |
615 |
| Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine. |
Ulrich-Merzenichm, G.; Koptina, A.; Kelber, O.; Freischmidt, A.; Heilmann, J.; Muller, J.; Sadeghlar |
Report |
Mar 1, 2012 |
6798 |
| Cathay International Holdings' Lansen awarded National Torch Program. |
|
|
Feb 27, 2012 |
175 |
| AN arthritis drug trialled in [...]. |
|
|
Feb 27, 2012 |
253 |
| Approval for drug after trial in North. |
|
|
Feb 22, 2012 |
253 |
| Glucocorticoid injections controlled early RA. |
Worcester, Sharon |
|
Feb 15, 2012 |
532 |
| Joint surgery growing less common in RA. |
McCall, Becky |
Clinical report |
Feb 15, 2012 |
514 |
| Companies' technologies combined in preclinical stem cell therapy for rheumatoid arthritis. |
|
|
Feb 13, 2012 |
308 |
| European partners to develop rheumatoid arthritis cell therapy. |
|
|
Feb 13, 2012 |
318 |
| Rheumatoid arthritis drug halts organ damage in inflammatory genetic disorder. |
|
|
Feb 11, 2012 |
598 |
| Benitec Biopharma and Medisterm Technologies combine in preclinical stem cell therapy for rheumatoid arthritis. |
|
|
Feb 7, 2012 |
218 |
| UCB, Astellas ink collaboration for rheumatoid arthritis drug Cimzia. |
|
|
Feb 1, 2012 |
114 |
| Benitec Biopharma, Medistem Technologies combine preclinical stem cell therapy for rheumatoid arthritis. |
|
Clinical report |
Feb 1, 2012 |
143 |
| Presentation of tuberculosis as isolated massive pericardial effusion in a patient with rheumatoid arthritis. |
|
|
Jan 31, 2012 |
1398 |
| Corticosteroids as disease modifying drugs in rheumatoid arthritis treatment. |
Yazici, Yusuf |
|
Jan 15, 2012 |
2294 |
| Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis: documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). |
Pincus, Theodore; Castrejon, Isabel |
Clinical report |
Jan 15, 2012 |
5423 |
| Short-term and long-term safety of glucocorticoids in rheumatoid arthritis. |
Saag, Kenneth G. |
Clinical report |
Jan 15, 2012 |
3757 |
| A fresh look at glucocorticoids: how to use an old ally more effectively. |
Buttgereit, Frank |
|
Jan 15, 2012 |
2640 |
| Circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. |
Haus, Erhard; Sackett-Lundeen, Linda; Smolensky, Michael H. |
Report |
Jan 15, 2012 |
4399 |
| Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care. |
Pincus, Theodore; Yazici, Yusuf; Castrejon, Isabel |
Clinical report |
Jan 15, 2012 |
2948 |
| UCB to compare Cimzia and Humira in head-to-head rheumatoid arthritis study. |
|
Report |
Dec 22, 2011 |
163 |
| UCB starts EXXELERATE clinical study for RA. |
|
Report |
Dec 21, 2011 |
220 |
| FDA accepts Pfizer's NDA for tofacitinib for rheumatoid arthritis. |
|
|
Dec 21, 2011 |
130 |
| Management of rheumatoid arthritis: consensus recommendations from the Turkish League Against Rheumatism / romatoid artritin tedavisi: Turkiye romatizma arastirma ve savas dernegi uzlasi onerileri. |
Ataman, Sebnem; Borman, Pinar; Evcik, Deniz; Aydog, Ece; Ayhan, Figen; Yildizlar, Derya; Bodur, Hati |
Report |
Dec 1, 2011 |
16674 |
| Lupus myositis with normal creatinine kinase levels following adalimumab use in a rheumatoid arthritis patient / bir romatoid artrit hastaslnda adalimumab kullanlmlnln ardlndan gelisen ve normal kreatinin kinaz seviyelerinin eslik ettigi lupus miyoziti. |
Almoallim, Hani; ALmasari, Ahlam; Khadawardi, Hadeel |
Report |
Dec 1, 2011 |
2427 |
